Skip to content
Clinical Trials – home
HungaryBack to Hungary

Clinical trials in Kalocsa – page 8

151 clinical trials in Kalocsa, Hungary. Every trial is listed in the EU Clinical Trials Register and updated daily.

Kalocsa at a glance
151
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

151 trials in Kalocsa

Open in trial search

Hypertriglyceridaemia

Not recruiting

Study on the Effects of Pegozafermin and Simvastatin for Patients with Severe High Triglycerides

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:BIO89-100
  • Sponsor:89bio Inc.

Study on the Effects of Maridebart Cafraglutide for Adults with Type 2 Diabetes

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.

A Study of Camizestrant Compared to Standard Hormone Therapy for Patients with ER-Positive HER2-Negative Early Breast Cancer After Initial Treatment

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:Astrazeneca AB

Schizophrenia

Not recruiting

Long-term Safety Study of Emraclidine for Adults with Schizophrenia

InvestigationalNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Emraclidine
  • Sponsor:Cerevel Therapeutics LLC

Crohn's disease

Not recruiting

Study Comparing Risankizumab and Ustekinumab for Adults with Moderate to Severe Crohn's Disease After Anti-TNF Therapy Failure

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Risankizumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Efficacy Comparison of Zanzalintinib (XL092) and Pembrolizumab Versus Pembrolizumab Monotherapy in PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Exelixis Inc.

Obesity

Not recruiting

Weight loss in adults with obesity (with or without type 2 diabetes) using cagrilintide and semaglutide: a study of two dose levels versus semaglutide alone

InvestigationalNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S

Obesity+1

Not recruiting

Study comparing two forms of cagrilintide with placebo for weight loss in adults with overweight or obesity

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S

Obesity

Not recruiting

Study of KAI-9531 in Adults With Obesity or Overweight and Weight-Related Health Problems Without Diabetes

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:HRS 9531
  • Sponsor:Kailera Therapeutics Inc.

A study testing tozorakimab for long-term treatment of chronic obstructive pulmonary disease in former smokers with repeated flare-ups

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol
  • Sponsor:Astrazeneca AB

Hyperlipidaemia

Not recruiting

A Study of Enlicitide and Rosuvastatin for Adults With High Cholesterol

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years
  • Substances:Enlicitide decanoate
  • Sponsor:Merck Sharp & Dohme LLC

Chronic kidney disease+1

Not recruiting

A study of ziltivekimab compared to placebo in people with heart and blood vessel disease, chronic kidney disease and inflammation

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S

Other cities in Hungary

The busiest research cities in the country

All 73 cities in Hungary

Clinical research in Kalocsa

What the registry says about research in the country

01 Cardiovascular Research

Studies focusing on heart failure prevention and innovative treatments for cardiovascular diseases. Key investigations include combination therapies with baxdrostat and research on blood pressure management.

  • Heart Failure Prevention
  • Resistant Hypertension
  • Atherosclerotic Disease

Novel approaches exploring cardiovascular outcomes in patients with various risk factors.

02 Metabolic Disorders

Comprehensive research into Type 2 Diabetes management and obesity treatments, evaluating new therapeutic approaches and combination medications.

  • Diabetes Management
  • Weight Management
  • Cardiovascular Safety Studies

Investigating innovative treatments to improve metabolic health outcomes.

03 Rheumatology Studies

Advanced research in rheumatoid arthritis and psoriatic arthritis treatments, including studies of novel biologics and long-term therapy effectiveness.

  • Arthritis Management
  • Osteoarthritis Treatment
  • Inflammatory Conditions

Evaluating new therapeutic options for chronic inflammatory conditions.

04 Mental Health Research

Innovative studies addressing major depressive disorder, schizophrenia, and other mental health conditions, focusing on new treatment approaches.

  • Depression Treatment
  • Schizophrenia Management
  • Alzheimer's Agitation

Testing novel therapeutic interventions for various psychiatric conditions.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.